Urothelial Carcinoma Recurrent
13 clinical trials · Condition
◉ Watch Urothelial Carcinoma Recurrent
| Record | Firm | Date |
|---|---|---|
| A Phase 1 Dose-escalation Study of UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC) (NCT05375903) | UroGen Pharma Ltd. | 2022-06-01 |
| En Bloc TURBT With Collins Loop vs Conventional TURBT (NCT05027412) | Hospital Universitario de Fuenlabrada | 2021-04-01 |
| A Study of Pemigatinib in Non-muscle Invasive Bladder Cancer Patients With Recurrent Low- or Intermediate-Risk Tumors (NCT03914794) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2020-10-02 |
| Vactosertib with Durvalumab in Urothelial Carcinoma Failing Checkpoint Inhibition (NCT04064190) | MedPacto, Inc. | 2019-12-13 |
| Named Patient Program for Mitomycin for Pyelocalyceal Solution (NCT05494411) | UroGen Pharma Ltd. |
Track Urothelial Carcinoma Recurrent automatically
Every clearance here is in the API, with alerts when new ones post.